Shree Ganesh BioTech (India) has informed that the Meeting of the Board of Directors of the Company held today on Monday, 30th July, 2018 and make Final call towards 1,81,00,000 Convertible Equity Warrants on Preferential basis from 7 Allottees and warrants are fully paid up and converted into equity shares of the Company.
The above information is a part of company’s filings submitted to BSE.